Premium
Commentary on ‘Changing prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase‐4 inhibitors’
Author(s) -
Fania L.,
Di Zenzo G.,
Mazzanti C.,
Abeni D.
Publication year - 2018
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.14965
Subject(s) - medicine , bullous pemphigoid , dipeptidyl peptidase 4 , diabetes mellitus , pemphigoid , dermatology , endocrinology , immunology , type 2 diabetes , antibody